PathfinderRegulatory Consulting
Regulatory strategy for medical devices

Guiding MedTech Teams Through Complex Regulatory Pathways

Strategic regulatory leadership to define clear pathways, reduce risk, and accelerate approvals across US and global markets.

Elizabeth George, RAC — Founder of Pathfinder Regulatory Consulting
  • Class III Medical Device Expertise
  • PMA · 510(k) · EU MDR
  • Former Medtronic Principal RA Specialist
  • RAC Certified
Services

Build the Right Regulatory Strategy — From the Start

A strong regulatory strategy begins early and evolves with your program. Pathfinder helps you define the most efficient path to approval while minimizing costly late-stage changes.

01

Regulatory Assessment

Before committing to a pathway, evaluate the regulatory landscape to define a clear starting point.

  • Device classification and potential submission pathways (PMA, 510(k), De Novo)
  • Preliminary indications for use and positioning
  • Identification of predicates and applicable product codes
  • Key regulatory risks and unknowns
02

Regulatory Strategy Development

A comprehensive, forward-looking regulatory plan tailored to your product and markets.

  • Define potential and preferred regulatory pathways
  • Align strategy with intended use, claims, and target markets
  • Identify key questions and decision points early
  • Develop timelines and submission sequencing
  • Anticipate testing, labeling, and documentation requirements
  • Conduct risk assessments to avoid costly rework
03

FDA & Global Submission Strategy

Strategic and hands-on support across the full submission lifecycle.

  • PMA, 510(k), and global submission planning
  • Modular and expedited pathways
  • Submission readiness and documentation strategy
  • Deficiency response planning and execution
04

Health Authority Engagement

Early and effective engagement with regulators — including FDA pre-submissions.

  • Develop pre-submission strategies and briefing packages
  • Align on regulatory expectations before development progresses too far
  • Reduce risk of late-stage surprises or major deficiencies
  • Support FDA and global agency interactions
05

Program Acceleration & Risk Mitigation

Avoid costly missteps and delays by embedding regulatory thinking early.

  • Identify risks related to novel technologies, indications, or populations
  • Anticipate post-approval requirements and reporting obligations
  • Guide teams on regulatory guardrails during development
  • Recover delayed programs and establish a clear path forward
Approach

Regulatory Shouldn't Be an Afterthought

Too often, regulatory strategy is brought in late — after key product decisions are already made. At that stage, changing direction becomes costly and time-consuming. Pathfinder works with teams early and throughout development, helping guide each stage.

  1. Stage 01

    Concept & Positioning

    Defining indications, intended use, and differentiation.

  2. Stage 02

    Development Planning

    Aligning testing, validation, and clinical strategy.

  3. Stage 03

    Regulatory Strategy

    Ensuring the chosen pathway is efficient and viable.

  4. Stage 04

    Submission & Approval

    Preparing documentation and managing agency interactions.

This approach ensures regulatory considerations are built into the program — not layered on at the end.

Signature impact

Proven Results in High-Risk Device Approvals

PMA approval achieved
56-day

Accelerated EU MDR timelines for high-risk devices through early alignment and parallel strategy execution.

  • 01Enabled faster approvals through early FDA alignment and parallel strategy execution
  • 02Reduced clinical burden through strategic use of clinical equivalence and evidence planning
  • 03Recovered delayed programs and advanced submission readiness timelines
  • 04Led global regulatory strategy across US, EU, and international markets
Who we partner with

Built for the Teams Bringing Complex Devices to Market

MedTech Startups

Preparing for early feasibility or pivotal studies.

PMA, 510(k) & EU MDR Programs

Companies navigating high-stakes submission pathways.

Expansion-Stage Companies

Teams expanding indications or entering new global markets.

Fractional Regulatory Leadership

Organizations needing senior regulatory leadership on a flexible basis.

Why Pathfinder

Senior Strategy, Not Tactical Backfill

Early, Strategic Involvement

Regulatory strategy is embedded from the beginning — reducing risk and avoiding costly pivots later.

Senior-Level Expertise

Work directly with an experienced regulatory leader with deep Class III device experience.

Clarity in Complexity

Translate evolving regulatory expectations into clear, actionable plans.

Efficient Path to Approval

Focus on the most streamlined path — balancing time, cost, and regulatory success.

Elizabeth George, Founder of Pathfinder Regulatory Consulting
About the founder

Elizabeth George, RAC

Founder & Principal Consultant

Pathfinder Regulatory Consulting was founded by Elizabeth George, RAC, a regulatory affairs leader specializing in global regulatory strategy for high-risk medical devices.

She previously served as a Principal Regulatory Affairs Specialist at Medtronic, where she led regulatory strategy for PMA and EU MDR programs and supported accelerated approvals for complex cardiovascular technologies.

Elizabeth brings a practical, results-driven approach — helping teams define clear regulatory pathways, align early with health authorities, and navigate complex development programs with confidence.

Credentials
RAC Certified
Previously
Principal RA, Medtronic
Get started

Define Your Path Forward

Whether you're at the concept stage or preparing for submission, Pathfinder Regulatory Consulting helps you identify the right regulatory strategy early — so you can move forward efficiently and avoid costly surprises.

Or reach out directly at elizabethgeorge@pathfinderregulatoryconsulting.com